StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$13.92−2.76 (-16.55%)

Close on Nov 17, 2026Market cap $1.01BP/E –Yield –

Omeros pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Omeros's pe ratio was 10.5× on Nov 11, 2026, against 5.4× a year earlier. Over the last 3 years it ranged from 0.7× to 11.0×, with a median of 5.4×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202610.5×+0.4
2024Jan 31, 202410.1×−0.1
2023Dec 29, 202310.2×+9.5
2022Dec 30, 20220.7×–

More Omeros figures

See a number that looks wrong?